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Study Design. Cross-sectional study.
Objective. The aim of this study was to study the personal and
societal impact of low back pain (LBP) in patients admitted to a
multidisciplinary spine center.
Summary of Background Data. The socioeconomic burden
of LBP is very high. A minority of patients visit secondary or
tertiary care because of severe and long-lasting complaints. This
subgroup may account for a major part of disability and costs,
yet could potentially gain most from treatment. Currently, little
is known about the personal and societal burden in patients with
chronic complex LBP visiting secondary/tertiary care.
Methods. Baseline data were acquired through patient-reported
questionnaires and health insurance claims. Primary outcomes
were LBP impact (Impact Stratification, range 8–50), functioning
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10.1097/BRS.00000000000031740–10), work participation, productivity costs (Productivity Cost
Questionnaire), and healthcare costs 1 year before baseline.
Healthcare costs were compared with matched primary and
secondary care LBP samples. Descriptive and inferential statistics
were applied.
Results. In total, 1502 patients (age 46.312.8 years, 57%
female) were included. Impact Stratification was 35.27.5 with
severe impact (35) for 58% of patients. PDI was 38.214.1,
EQ5D 0.39 (interquartile range, IQR: 0.17–0.72); WAS 4.0
(IQR: 1.0–6.0) and 17% were permanently work-disabled. Mean
total health care costs (s4875, 95% confidence interval [CI]:
4309–5498) were higher compared to the matched primary care
sample (n¼ 4995) (s2365, 95% CI: 2219–2526, P<0.001), and
similar to the matched secondary care sample (n¼4993)
(s4379, 95% CI: 4180–4590). Productivity loss was estimated
at s4315 per patient (95% CI: 3898–4688) during 6 months.
Conclusion. In patients seeking multidisciplinary spine care,
the personal and societal impact of LBP is very high. Specifi-
cally, quality of life and work ability are poor and health care
costs are twice as high compared to patients seeking primary
LBP care.
Key words: chronic pain, multidisciplinary care, tertiary care,
questionnaire, self-report, functioning, disability, quality of life,
work ability, productivity loss, healthcare costs, health
economics.
Level of Evidence: 3
Spine 2019;44:E1443–E1451L
ow back pain (LBP) is the leading cause of disability
in Western countries. Years lived with disability
caused by LBP increased with 54% between 1990
and 2015 and continue to increase because of a growing and
ageing population.1 Although most people recover rather
quickly from a new episode of LBP, one in five adults
develops chronic disabling LBP.2 As a result, the socioeco-
nomic burden of LBP is very high. In Western countries, the
societal costs for back pain are estimated to be 1% to 2% of
the gross national product.3–5 The majority of these costs
(80%–90%) is caused by productivity loss and disability.3,6www.spinejournal.com E1443
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of disability and it may be assumed that they account for the
majority of costs as well. Less than 28% of LBP cases fall in
severe categories, but are responsible for 77% of all years
lived with disabilities.7 This subgroup of patients with
persistent disabling LBP has potentially most to gain from
effective treatment. Current guidelines recommend multi-
disciplinary biopsychosocial treatment programs for
patients with LBP who have not responded to first-line
treatment.8–10 However, for both multidisciplinary pain
treatment and more invasive approaches, such as spinal
surgery, there is only low to moderate level of evidence that
intervention treatments are effective in the short and
medium term. Furthermore, effect sizes are small to moder-
ate and very little is known about the effectiveness of LBP
treatments in the longer term.11–14
In 2015, the Groningen Spine Cohort (GSC) was initiated
to gain a better understanding of the course and prognosis of
pain, disability, quality of life, work participation, and
medical consumption, as well as the quality and effective-
ness of care in patients with LBP seeking multidisciplinary
secondary or tertiary care. Data on short-, medium-, and
long-term outcomes of LBP are collected using medical
records, health insurance data, and patient self-report.
The GSC will serve as basis for multiple future studies.
In this first article, we present an extensive overview of all
baseline patient characteristics. We also present healthcare
costs and productivity costs to answer the following ques-
tion: what is the personal and societal impact of LBP in




The GSC study is a 10-year prospective cohort study of
patients with LBP referred to a university-based multidisci-
plinary secondary (patient referred by general practitioner,
GP) and tertiary (patient referred by medical specialist, MS)
care spine center, the Groningen Spine Center, in the north of
the Netherlands. Inclusion of patients ran from July 2015 to
July 2018. Baseline and follow-up data are acquired through
digital questionnaires and health insurance claims. Before
first consultation, all patients digitally filled out a compre-
hensive set of baseline questionnaires (45min). The present
study reports results of the baseline questionnaires and
presents an overview of health insurance 1 year before base-
line and costs of productivity loss 6 months before baseline.
The Medical Ethical Committee of the University Medical
Center Groningen, the Netherlands provided a waiver
(M15.169472) for this study with respect to medical ethical
permission. Handling of the data was done in accordance
with the guidelines for Good Research Practice.15
Patients and Setting
Patients referred to the Groningen Spine Center, between 18
and 65 years’ old, with LBP and/or leg pain were eligible forE1444 www.spinejournal.cominclusion. All patients were informed on the purpose of the
study and signed an informed consent for the use of their
health and insurance data based on anonymity. Patients who
did not understandDutch language or had no Internet access
were excluded. All patients received care as usual, and
inclusion or exclusion did not change content of the treat-
ment. Treatment could consist of minimal intervention only
(reassurance, pain education and information), or could be
combined with surgery, multidisciplinary rehabilitation,
pain anesthesiology treatment, and/or other if needed (for
example referral and treatment by a rheumatologist). Opti-
mal triaging and treatment modalities of patients were
discussed in a weekly multispecialist meeting with neuro-
surgeons, neurologists, rehabilitation physicians, radiolog-
ists, orthopedic surgeons, anesthesiologists, and physician
assistants.Measures
Questionnaires
National Institutes of Health Minimal Dataset
The National Institutes of Health (NIH) minimal dataset
includes 40 items on patient characteristics, medical history,
and self-reported symptoms and functioning.16 Nine of
these items (Numerical Rating Scale, NRS, pain, range:
0–10; four items on pain interference, range: 1–5; and four
items on physical function, range: 1–5) were used to create
an outcome score, the Impact Stratification. The total score
on the Impact Stratification ranges from 8 (least impact) to
50 (most impact) and is classified by the NIH Research Task
Force as mild (8–27 points), moderate (28–35 points), or
severe impact (35 points).16 The Impact Stratification
strongly correlates with measures such as the RolandMorris
Disability Questionnaire and the Oswestry Disability
Index.16
Disability
The Pain Disability Index (PDI) measures self-reported
disability for seven categories of daily life activities: fam-
ily/home responsibilities, recreation, social activity, occupa-
tion, sexual behavior, self-care, and life support activity.
Each item is constructed on a numeric rating scale with 0
indicating no disability and 10 indicating maximum disabil-
ity revealing total scores from 0 to 70. The Dutch version of
the PDI is responsive and 2-week test–retest reliability is
good.17,18
Quality of Life
Quality of life was measured with the three-level version of
the Euroqol-5D (EQ5D) questionnaire.19 Five dimensions
(mobility, self-care, usual activities, pain/discomfort, and
anxiety/depression) are measured on three levels each (no
problems, some problems, extreme problems). Using a vali-
dated algorithm,20 the EQ5D scores can be converted into a
utility value (ranging from 0.33 to 1). Validity, reliability,
and responsiveness of the EuroQol-5D are sufficient.21,22 InDecember 2019
EPIDEMIOLOGY Personal and Societal Impact of LBP  Dutmer et aladdition, patient-reported health status is measured on a
visual analogue scale (EQ-VAS, range 0–100, worst to best
health status).
Work Ability
The Work Ability Score (WAS) measures the self-reported
current work ability compared to lifetime best. Scores range
from 0 to 10, classified as excellent (10 points), good (8–9
points), moderate (6–7 points), and poor (0–5 points) work
ability.23 TheWAShas been demonstrated to be a good quick
alternative for the Work Ability Index (WAI) for assessing
work ability in occupational and primary health care.24
Convergent validity between the WAS and WAI is accept-
able.25
Psychosocial Work Environment
Psychosocial work environment was measured with a cus-
tomized version of the short Copenhagen Psychosocial
Questionnaire (COPSOQ II).26 Twenty-five items on a
five-point Likert scale cover domains such as (mental) work
demands, work organization and job contents, interper-
sonal relationship and leadership, and the work-individual
interface. Test–retest reliability is adequate to good for the
selected items of the customized version.27
Productivity Loss
Health-related productivity losses were measured with the
Institute for Medical Technology Assessment Productivity
Cost Questionnaire (iPCQ).28 The iPCQ has a recall period
of 4 weeks. Two modules measure productivity losses of
paid work because of absenteeism and presenteeism. For the
present study, the module on absenteeism was expanded
with items specifying whether the absence of work was
because of LBP. The items on absenteeism and presenteeism
have been validated.29
Additional Items
Additionally, at baseline, patients answered medical and
job-related questions about previous hospital visits and
imaging for their current LBP (hospital, year, specialty,
imaging type), LBP red flags (previous history of cancer,
unexplained weight loss, pain worse at night, systemically
unwell, prolonged use of corticosteroids, morning stiffness
>1 hour, recent trauma, predominant leg pain), use of pain
medication (paracetamol, nonsteroidal anti-inflammatory
drugs, opioids, other), and job characteristics (weekly hours,
responsibilities, physical demands, adjustments owing to
health concerns, and so on).
Health Insurance Claims
Medical costs were obtained from patients who were
insured with one of the main Dutch health insurance com-
panies. We expected about 40% of GSC patients to be
insured by this company. TheDutch health insurance system
is based on managed competition and Dutch citizens are
required to obtain a basic insurance package from a health
insurer of their choice.30 Out-of-pocket medical costs were
not collected. Health insurance claims were collected 1 yearSpineretrospectively before inclusion. A 14-month delay in




Both total health insurance costs and LBP-related costs were
calculated. LBP-related costs were acquired by taking the
sum of all health insurance claims that were likely to be
related to LBP, for example, claims for pain medication,
physiotherapy, medical specialist consults, back related
surgery, or other interventions. Health insurance costs of
GSC patients were compared to health insurance costs of
patients with LBP who did not seek tertiary LBP care. The
health insurance company provided 1-year total health
insurance costs for two matched (age/sex) samples of
patients seeking primary (n¼4995) or secondary care
(n¼4993) for LBP.
Costs of Productivity Loss
For the absenteeism module of the iPCQ, patients reported
the number of sick days in the past 4 weeks.28,31 If a patient
was on sick leave since before the 4-week recall period they
also filled out the date the sick leave started. The number of
sick days in the 4-week recall period were extrapolated to
6 months (26 weeks) before baseline by multiplying it by
6.5. Absenteeism costs were then calculated by multiplying
the total number of sick days by mean daily working hours
and by costs of production loss per hour (2015; s31.80 for
women, s38.10 for men).31 Absenteeism costs were calcu-
lated using the friction cost method (FCM), which assumes
that after a period of 85 days another worker has fully
replaced the absent patient.31–33 This implies that patients
who are disabled for work do not incur productivity costs
anymore, as they have been out of the productive process for
>85 days. Costs of productivity loss owing to presenteeism,
that is, working while sick, were calculated using the num-
ber of affected work hours, an efficiency score (numerical
rating scale, 0–10) that patients ascribed to their ability to
work during those hours, and by the costs of production loss
per hour. The sum of costs owing to absenteeism and
presenteeism represents the total costs of productivity loss
for paid work. Missing data on weekly work hours (in 14%
of employed patients) and weekly work days (in 7% of
employed patients) were handled with multiple imputation.
Constraints were set on the minimum and maximum num-
ber of work hours (between 2 and 40hours) and work days
(between 1 and 5) per week.
Statistical Analyses
Descriptive statistics were applied to present baseline
patient characteristics. Continuous data are reported as
means and standard deviations or medians and interquartile
range (IQR), depending on the distribution of the data.
Categorical data are presented as frequencies with percen-
tages. Cost data are presented as means with 95%www.spinejournal.com E1445
Figure 1. Flow chart of patient inclusion.
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clinical and work-related primary outcome measures and
health insurance data are presented separately for patients
whowere referred to theGroningen Spine Center by their GP
or by an MS. Between-group differences for the two referral
subgroups were tested with an independent t test, Mann–
WhitneyU, or Pearsonx2 depending on level ofmeasurement
and distribution of data. SPSS software (version 23.0, IBM
Corp., Armonk, NY) was used for data analysis. A P value of
0.05 was considered statistically significant.
RESULTS
A total of 1502 patients from the Groningen Spine Cohort
were included in this study (Figure 1 and Table 1). An
extensive overview of patient characteristics and clinicalE1446 www.spinejournal.combaseline results per item can be found in Appendix 1,
http://links.lww.com/BRS/B448. Patients had an average
age of 46.312.8 years and the majority (57%) were
female. Apart from 41 patients, all patients had developed
chronic (>3 months) LBP. Exercise therapy was the most
common type of treatment used (at any point in time) for
LBP (88%), followed by opioids (53%), and LBP opera-
tion(s) (26%). The majority of patients (58%) had a score
35 as measured with the Impact Stratification (severely
impacted by the LBP). Quality of life was low with a median
EQ5D utility score of 0.39 (IQR: 0.17–0.72) and a health
state (EQ-VAS) score of 52.919.7 of 100. Patients scored
their work ability a 4.0 (IQR: 1.0–6.0) of 10 and 17% of
patients were permanently work-disabled (i.e., absenteeism
exceeds 2 years). Compared to patients who were referredDecember 2019









Age, y, mean SD 46.3 12.8 45.3 12.9 47.5 12.7
Sex, n (%)
Female 857 (57) 474 (56) 383 (59)
Education level, n (%)
No education 29 (2) 19 (2) 10 (2)
Low 522 (35) 266 (31) 256 (39)
Middle 487 (32) 283 (33) 204 (31)
High 343 (23) 224 (26) 119 (18)
Other 121 (8) 71 (7) 60 (9)
Medical history
Duration LBP, n (%)
<3 mo 40 (3) 30 (4) 10 (2)
3 mo–1 y 240 (16) 139 (16) 101 (16)
1–5 y 527 (35) 278 (33) 249 (38)
>5 y 695 (46) 406 (48) 289 (45)
Previous medical imaging for current LBP, n (%) 1328 (88) 696 (82) 632 (96)
Visited medical specialist for current LBP, n (%) 822 (55)y 398 (47)z, 424 (66)§,
Previous low-back operation(s), n (%) 387 (26) 181 (21) 206 (32)
Treatment(s) used for LBP, n (%)
Opioids 803 (53) 418 (49) 385 (59)
Injections 328 (22) 147 (17) 181 (28)
Exercise therapy 1316 (88) 785 (89) 558 (86)
Psychological counseling 222 (15) 128 (15) 94 (15)
Pain and functioning
NRS score back pain (0–10), median (IQR) 7.0 (6.0–8.0) 7.0 (6.0–8.0) 7.0 (6.0–8.0)
PDI total (0–70), mean SD 38.2 14.1 37.0 14.1 39.8 13.8
NIH minimal dataset Impact Stratification (8–50),
mean SD
35.27.5 34.77.5 36.07.3
Mild (8–27), n (%) 232 (16) 144 (17) 88 (14)
Moderate (28–34), n (%) 402 (26) 242 (28) 160 (25)
Severe (35), n (%) 868 (58) 467 (55) 401 (62)
Quality of life
EQ5D: health state (0–100), mean SD 52.919.7jj 54.419.8{, 51.119.4#,
EQ5D: utility value (0.33 to 1.00), median (IQR) 0.39 (0.17–0.72) 0.57 (0.19–0.73) 0.30 (0.17–0.69)
Work
Work ability (0–10), median (IQR) 4.0 (1.0–6.0) 5.0 (1.0–6.0) 3.0 (1.0–6.0)
Work status, n (%)
Not working 601 (40) 296 (35) 305 (47)
Permanent work disability 253 (17) 125 (15) 128 (20)
Employed 901 (60) 557 (65) 344 (53)
Working 409 (27) 271 (32) 138 (21)
Partial sick leave 260 (17) 161 (19) 99 (15)
Sick leave 232 (15) 125 (15) 107 (17)
EQ5D indicates Euroqol-5D; GP, general practitioner; IQR, interquartile range: quartile 1 to quartile 3; LBP, low back pain; MS, medical specialist; N, number
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TABLE 2. Health Insurance Costs in Euros 1 Year Before Receiving LBP Care
Sample N Mean Costs (CI)
Groningen Spine Cohort (secondary/tertiary care)
All patients Total 436 4875 (4309–5498)
LBP-related 435 2175 (1852–2547)
Patients referred by GP Total 254 3459 (2898–4077)
LBP-related 253 1569 (1249–1947)
Patients referred by MS Total 182 6852 (5648–8017)
LBP-related 182 3018 (2459–3719)
Matched controls
Primary care Total 4995 2365 (2219–2526)
Secondary care Total 4993 4379 (4180–4590)
CI indicates bootstrapped 95% confidence interval for mean: lower bound to upper bound; GP, general practitioner; LBP, low back pain; MS, medical
specialist; N, number of patients.
EPIDEMIOLOGY Personal and Societal Impact of LBP  Dutmer et alby their GP (57%), patients who were referred by an MS
(43%) were older, lower educated, had more often received
treatment in the form of surgery, opioids, or injections for
LBP, were more disabled, and more severely impacted by
their LBP, scored lower on quality of life, and were more
often unemployed or on permanent work disability.
Health insurance costs were available for 436 patients
(29%) (Table 2). Mean costs for the total GSC sample
(s4875; 95% confidence interval [CI]: 4309–5498) were
significantly higher than for the matched primary care
sample (s2365; 95% CI: 2219–2526; P<0.001) but did
not differ significantly from the matched secondary care
sample (s4379; CI: 4180–4590; P¼0.23). Almost half
(s2175; 95% CI: 1852–2547) of the total health insurance








Total productivity loss Total 751




Total productivity loss Total 461




Total productivity loss Total 290
CI indicates bootstrapped 95% confidence interval for mean: lower bound to upp
specialist; N, number of patients.
Amount of patients who reported sick leave. Some patients still had zero costs as
into account the replacement of absent workers after 85 days.
E1448 www.spinejournal.comGroningen Spine Center were back pain-related. GSC
patients who were referred to the Groningen Spine Center
through their GP had significantly lower costs (s3458; 95%
CI: 2898–4077) than those who were referred by an MS
(s6851; 95% CI: 5648;8017; P<0.001).
A total of 387 of 901 employed patients in the GSC
reported sick days in the 6 months before visiting the
Groningen Spine Center, which resulted in mean (friction)
costs of s1615 (95% CI: 1392–1882) per GSC patient
(Table 3). For 85% of patients, LBP was the cause of their
sick day(s) (s1380; 95% CI: 1181–1598). A total of 566
patients were affected by reduced productivity while at
work, resulting in mean costs of s2700 (95% CI: 2442–
2969) per GSC patient. Costs for absenteeism, absenteeism
owing to LBP, presenteeism, and total productivity loss wereuros 6 Months Before Baseline (Friction Cost
Mean Costs Per
Affected Patient (CI)
Mean Costs Per GSC
Patient, n¼1502 (CI)
 6546 (5773–7305) 1615 (1392–1882)
 6560 (5814–7269) 1380 (1181–1598)
7165 (6683–7683) 2700 (2442–2969)
 8773 (8190–9400) 4315 (3898–4688)
 7540 (6633–8469) 1982 (1655–2328)
 7675 (6641–8823) 1704 (1395–2065)
7130 (6513–7807) 2984 (2650–3312)
 9300 (8423–10242) 4966 (4435–5585)
 5074 (4156–6017) 1132 (866–1416)
 4903 (3859–5912) 954 (710–1238)
7225 (6388–8103) 2327 (1968–2726)
 7936 (6952–8985) 3459 (2908–4059)
er bound; GP, general practitioner; LBP, low back pain; MS, medical
a result of their sick leave when using the friction cost method, which takes
December 2019
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(presenteeism: P<0.05, absenteeism and total productivity
loss: P<0.001).
DISCUSSION
The objective of this study was to assess the personal and
societal impact of LBP in patients seeking multidisciplinary
secondary and tertiary spine care.We found that patients had
an extensive medical history related to their LBP and pre-
sented with very low functioning and quality of life. One-
thirdofpatientswere either on sick leaveorwerepermanently
work-disabled. Health insurance costs were twice as high
compared to patients seeking primary LBP care and most
employed patients reported productivity loss. Patients who
were referred to the Groningen Spine Center by an MS were
more severely impacted by their LBP than those referred by
their GP.
Almost all patients referred to the Groningen Spine
Center presented with chronic (>3 months) LBP. A wide
variety of interacting biopsychosocial factors have been
recognized to contribute to chronic disabling LBP and could
have potentially played a role in the recurrence and com-
plexity of LBP in our patient sample.6 Most notable in our
cohort were the presence of leg pain,34,35 multisite pain,34,36
catastrophizing,34 and feelings of depression and/or anxi-
ety34,36 (Appendix 1, http://links.lww.com/BRS/B448). Still,
many factors and underlying mechanisms associated with
the transition to persistent disabling LBP are yet unknown.6
Two-thirds of patients reported severe pain (NRS pain
>7), which aligns with other Dutch LBP and chronic pain
samples in primary, secondary, and tertiary care.37–41 Dis-
ability scores, as measured with the PDI, were also similar to
those of Dutch chronic pain patients in secondary care.39,42
Quality of life, however, was very low among GSC patients.
The EQ5D utility score for the general Dutch adult popula-
tion is approximately 0.91.43 Patients with LBP in primary
care scored on average between 0.61 and 0.67.37,40 Higher
scoreswere also observed in cancer studies,where themedian
utility scorewas 0.75.44Althoughother studies have reported
onone or few characteristics, this is the first studyweknowof
that reported on multiple characteristics, all showing high
personal impact, thus physical, psychological, social, and
economic consequences of LBP for the individual patient.
In addition, this study adds health insurance and productivity
data, demonstrating high societal impact, as well.
Patients’ health insurance costs in the year before visiting
the Groningen Spine Center were slightly higher compared
to patients with LBP seeking secondary care, but twice as
high compared to patients seeking primary LBP care.
Healthcare consumption for the general Dutch population
aged 20 to 65 years is lower at approximately s2100 per
year (source: www.vektis.nl/streams/open-data). Almost
half of the insurance costs in our sample could be contrib-
uted to LBP-related care. Higher LBP-related costs (s4015)
were reported in patients with discogenic LBP referred to
specialized pain care.38 However, that study also included
direct nonmedical costs such as travel costs. Overall, in theSpineyear leading up to seeking multidisciplinary LBP care, GSC
patients were likely to have already spent >s2000 on back
pain-related care.
The work ability of patients in the GSCwas poor (median
WAS: 4.0). Seventeen percent of patients were on permanent
work disability, whereas on average 6% of the working age
population in the Netherlands rely on disability benefits.45
Return to work is associated with significant improvements
in health,46,47 but unfortunately the probability of returning
to work for patients on permanent work disability is low.48
Work ability was higher, but still poor, for employed
patients (median WAS: 5.0) and moderate for employed
patients who were working fully (median WAS: 7.0). The
average WAS score for nonsicklisted workers from a variety
of work fields is 8.0 (SD: 1.1).49
Productivity loss costs owing to absenteeism were s1615
per patient during 6 months. The majority (85%) of patients
reporting sick leave did so because of back pain. Cost-of-
illness studies are notoriously difficult to compare because
of little standardization across studies and international
variations in health economic guidelines. In the
Netherlands, we have endorsed the FCM, which typically
produces smaller estimates of productivity losses compared
to the human capital method (ranging from twice to 19
times less costs).50 Using the FCM, a German study on
patients with chronic LBP in primary care found signifi-
cantly lower absenteeism costs of s577 during 6 months.51
Assuming relatively constant productivity costs in the year
before visiting a spine center, a Dutch study on patients in
specialized LBP care, using the FCM, reported higher absen-
teeism costs (s3778) during a period of 12 months.38
This study demonstrates that in higher levels of care there
is a higher burden of LBP for patients. The impact on quality
of life, work ability, and medical consumption is highest for
patients seeking tertiary care (referred by MS), followed by
secondary (referred by GP), and primary LBP care. Results
on societal costs, however, show that patients referred by
their GP accrued higher costs than patients referred by an
MS, as a result of productivity loss in the 6 months before
baseline. This may seem counterintuitive, but can be partly
explained by the fact that among the patients referred by
their MS, the percentage not working and disabled was
higher than in patients referred by the GP. Productivity costs
can only be incurred by those currently having a paid job.
Furthermore, a higher percentage of employed patients in
the MS group compared to the GP group (28% vs. 13%)
were on sick leave for >267 days (6 months before baseline
plus the 85 days friction period), which also lead to zero
productivity costs within the applied FCM.
There are some limitations and considerations to this
study. First, as the majority of data were collected through
patient questionnaires, a potential self-reporting bias could
have occurred.52 Second, the calculated health consumption
is an approximation of total medical costs because we did
not include direct nonmedical costs or out-of-pocket medi-
cal costs. Also, LBP-related health care costs were probably
slightly overestimated. All claims with a high probability ofwww.spinejournal.com E1449
EPIDEMIOLOGY Personal and Societal Impact of LBP  Dutmer et albeing LBP-related were labeled as such but could still be
utilized for different reasons (e.g., pain medication). Never-
theless, a strength of our approach was the use of objective
cost data instead of self-report, which excludes recall bias.
Productivity loss data could be subjected to recall bias and
extrapolating from a 4-week period to 6 months could
under- or overestimate productivity loss costs. However,
almost all patients reported chronic LBP, so we have reason
to believe that productivity loss would not vary greatly
during the 6 months before baseline.
CONCLUSION
In patients seeking multidisciplinary secondary and tertiary
spine care, the personal and societal impact of LBP is very
high. Despite having exhausted a wide variety of health care
resources, as demonstrated by an extensive medical history
and high health care costs, functioning, quality of life, and
work ability are still very poor. Multidisciplinary spine care
should target those patients that are most likely to respond
to treatment to reduce the personal burden of LBP and to
prevent further accumulation of health care costs and pro-
ductivity loss.E1Key Points450Patients presenting in multidisciplinary secondary
and tertiary spine care were severely impacted by
their LBP. Specifically, quality of life and work
ability were poor.
Health care costs were twice as high compared to
patients seeking primary LBP care.
Productivity costs were on average s4315 per
patient, with 43% of employed patients reporting
sick leave in the last 6 months.
Patients referred to multidisciplinary spine care by
a medical specialist were more severely impacted
than those referred by their GP.Supplemental digital content is available for this article.
Direct URL citations appearing in the printed text are
provided in the HTML and PDF version of this article on
the journal’s Web site (www.spinejournal.com).
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